Co-Authors
This is a "connection" page, showing publications co-authored by MYRNA GODOY and BRETT CARTER.
Connection Strength
1.947
-
Incidental Findings in Lung Cancer Screening: Which Ones are Relevant? Semin Roentgenol. 2017 Jul; 52(3):156-160.
Score: 0.147
-
IASLC/ITMIG Staging System and Lymph Node Map for Thymic Epithelial Neoplasms. Radiographics. 2017 May-Jun; 37(3):758-776.
Score: 0.146
-
ITMIG Classification of Mediastinal Compartments and Multidisciplinary Approach to Mediastinal Masses. Radiographics. 2017 Mar-Apr; 37(2):413-436.
Score: 0.144
-
Predicting Malignant Nodules from Screening CTs. J Thorac Oncol. 2016 12; 11(12):2045-2047.
Score: 0.142
-
Current Controversies in Lung Cancer Staging. J Thorac Imaging. 2016 Jul; 31(4):201-14.
Score: 0.138
-
Pitfalls in pulmonary nodule characterization. Semin Roentgenol. 2015 Jul; 50(3):164-74.
Score: 0.125
-
Computed tomography imaging of lung infection in the oncologic setting: typical features and potential pitfalls. Semin Roentgenol. 2015 Jul; 50(3):192-6.
Score: 0.125
-
Imaging of the mediastinum: vascular lesions as a potential pitfall. Semin Roentgenol. 2015 Jul; 50(3):241-50.
Score: 0.125
-
Lung cancer screening: how to do it. Semin Roentgenol. 2015 Apr; 50(2):82-7.
Score: 0.123
-
Multimodality imaging of cardiothoracic lymphoma. Eur J Radiol. 2014 Aug; 83(8):1470-82.
Score: 0.119
-
Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Randomized Clinical Trial. JAMA Intern Med. 2025 Jan 13.
Score: 0.062
-
Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer. J Immunother Cancer. 2024 Oct 23; 12(10).
Score: 0.061
-
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial. Nat Med. 2023 03; 29(3):593-604.
Score: 0.055
-
Author Correction: Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma. Nat Commun. 2021 May 12; 12(1):2888.
Score: 0.048
-
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial. Nat Med. 2021 03; 27(3):504-514.
Score: 0.048
-
Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas. Nat Commun. 2021 01 29; 12(1):687.
Score: 0.047
-
18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer. Cancer Immunol Immunother. 2020 Aug; 69(8):1519-1534.
Score: 0.045
-
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma. Nat Commun. 2019 07 05; 10(1):2978.
Score: 0.043
-
Incidental Findings on Lung Cancer Screening: Significance and Management. Semin Ultrasound CT MR. 2018 Jun; 39(3):273-281.
Score: 0.039
-
Lung Cancer: Postoperative Imaging and Complications. J Thorac Imaging. 2017 Sep; 32(5):276-287.
Score: 0.037
-
Characterizing proton-activated materials to develop PET-mediated proton range verification markers. Phys Med Biol. 2016 06 07; 61(11):N291-310.
Score: 0.034
-
Pitfalls in oncologic imaging: complications of chemotherapy and radiotherapy in the chest. Semin Roentgenol. 2015 Jul; 50(3):183-91.
Score: 0.031
-
Lung cancer screening-why do it? Tobacco, the history of screening, and future challenges. Semin Roentgenol. 2015 Apr; 50(2):72-81.
Score: 0.031
-
Malignant pleural mesothelioma: role of CT, MRI, and PET/CT in staging evaluation and treatment considerations. Semin Roentgenol. 2013 Oct; 48(4):323-34.
Score: 0.029